Literature DB >> 32033922

Preliminary Report on the Effects of a Low Dose of LSD on Resting-State Amygdala Functional Connectivity.

Anya K Bershad1, Katrin H Preller2, Royce Lee3, Sarah Keedy3, Jamie Wren-Jarvis3, Michael P Bremmer3, Harriet de Wit4.   

Abstract

BACKGROUND: The practice of "microdosing," or the use of repeated, very low doses of lysergic acid diethylamide (LSD) to improve mood or cognition, has received considerable public attention, but empirical studies are lacking. Controlled studies are needed to investigate both the therapeutic potential and the neurobiological underpinnings of this pharmacologic treatment.
METHODS: The present study was designed to examine the effects of a single low dose of LSD (13 μg) versus placebo on resting-state functional connectivity and cerebral blood flow in healthy young adults. Twenty men and women, 18 to 35 years old, participated in 2 functional magnetic resonance imaging scanning sessions in which they received placebo or LSD under double-blind conditions. During each session, the participants completed drug effect and mood questionnaires, and physiological measures were recorded. During expected peak drug effect, they underwent resting-state blood oxygen level-dependent and arterial spin labeling scans. Cerebral blood flow as well as amygdala and thalamic connectivity were analyzed.
RESULTS: LSD increased amygdala seed-based connectivity with the right angular gyrus, right middle frontal gyrus, and the cerebellum, and decreased amygdala connectivity with the left and right postcentral gyrus and the superior temporal gyrus. This low dose of LSD had weak and variable effects on mood, but its effects on positive mood were positively correlated with the increase in amygdala-middle frontal gyrus connectivity strength.
CONCLUSIONS: These preliminary findings show that a very low dose of LSD, which produces negligible subjective changes, alters brain connectivity in limbic circuits. Additional studies, especially with repeated dosing, will reveal whether these neural changes are related to the drug's purported antidepressant effect.
Copyright © 2019 Society of Biological Psychiatry. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Amygdala; Connectivity; Depression; LSD; Microdose; fMRI

Mesh:

Substances:

Year:  2019        PMID: 32033922      PMCID: PMC7150630          DOI: 10.1016/j.bpsc.2019.12.007

Source DB:  PubMed          Journal:  Biol Psychiatry Cogn Neurosci Neuroimaging        ISSN: 2451-9022


  34 in total

Review 1.  The standardized psychometric assessment of altered states of consciousness (ASCs) in humans.

Authors:  A Dittrich
Journal:  Pharmacopsychiatry       Date:  1998-07       Impact factor: 5.788

2.  Psilocybin modulates functional connectivity of the amygdala during emotional face discrimination.

Authors:  O Grimm; R Kraehenmann; K H Preller; E Seifritz; F X Vollenweider
Journal:  Eur Neuropsychopharmacol       Date:  2018-04-25       Impact factor: 4.600

3.  Acute Subjective and Behavioral Effects of Microdoses of Lysergic Acid Diethylamide in Healthy Human Volunteers.

Authors:  Anya K Bershad; Scott T Schepers; Michael P Bremmer; Royce Lee; Harriet de Wit
Journal:  Biol Psychiatry       Date:  2019-06-03       Impact factor: 13.382

Review 4.  Recognizing emotion from facial expressions: psychological and neurological mechanisms.

Authors:  Ralph Adolphs
Journal:  Behav Cogn Neurosci Rev       Date:  2002-03

5.  Functional coupling of the amygdala in depressed patients treated with antidepressant medication.

Authors:  Chi-Hua Chen; John Suckling; Cinly Ooi; Cynthia H Y Fu; Steve C R Williams; Nicholas D Walsh; Martina T Mitterschiffthaler; Emilio Merlo Pich; Ed Bullmore
Journal:  Neuropsychopharmacology       Date:  2007-11-07       Impact factor: 7.853

Review 6.  Emotional valence modulates brain functional abnormalities in depression: evidence from a meta-analysis of fMRI studies.

Authors:  Nynke A Groenewold; Esther M Opmeer; Peter de Jonge; André Aleman; Sergi G Costafreda
Journal:  Neurosci Biobehav Rev       Date:  2012-12-01       Impact factor: 8.989

Review 7.  Disorders of the cerebellum: ataxia, dysmetria of thought, and the cerebellar cognitive affective syndrome.

Authors:  Jeremy D Schmahmann
Journal:  J Neuropsychiatry Clin Neurosci       Date:  2004       Impact factor: 2.198

Review 8.  Recommended implementation of arterial spin-labeled perfusion MRI for clinical applications: A consensus of the ISMRM perfusion study group and the European consortium for ASL in dementia.

Authors:  David C Alsop; John A Detre; Xavier Golay; Matthias Günther; Jeroen Hendrikse; Luis Hernandez-Garcia; Hanzhang Lu; Bradley J MacIntosh; Laura M Parkes; Marion Smits; Matthias J P van Osch; Danny J J Wang; Eric C Wong; Greg Zaharchuk
Journal:  Magn Reson Med       Date:  2014-04-08       Impact factor: 4.668

9.  The mixed serotonin receptor agonist psilocybin reduces threat-induced modulation of amygdala connectivity.

Authors:  Rainer Kraehenmann; André Schmidt; Karl Friston; Katrin H Preller; Erich Seifritz; Franz X Vollenweider
Journal:  Neuroimage Clin       Date:  2015-08-22       Impact factor: 4.881

10.  Effect of a single dose of citalopram on amygdala response to emotional faces.

Authors:  Susannah E Murphy; Raymond Norbury; Ursula O'Sullivan; Philip J Cowen; Catherine J Harmer
Journal:  Br J Psychiatry       Date:  2009-06       Impact factor: 9.319

View more
  14 in total

1.  Hallucinogens in Mental Health: Preclinical and Clinical Studies on LSD, Psilocybin, MDMA, and Ketamine.

Authors:  Danilo De Gregorio; Argel Aguilar-Valles; Katrin H Preller; Boris Dov Heifets; Meghan Hibicke; Jennifer Mitchell; Gabriella Gobbi
Journal:  J Neurosci       Date:  2020-11-30       Impact factor: 6.167

2.  Low doses of LSD reduce broadband oscillatory power and modulate event-related potentials in healthy adults.

Authors:  Conor H Murray; Ilaria Tare; Claire M Perry; Michael Malina; Royce Lee; Harriet de Wit
Journal:  Psychopharmacology (Berl)       Date:  2021-10-06       Impact factor: 4.530

Review 3.  New Paradigms of Old Psychedelics in Schizophrenia.

Authors:  Danish Mahmood; Sattam K Alenezi; Md Jamir Anwar; Faizul Azam; Kamal A Qureshi; Mariusz Jaremko
Journal:  Pharmaceuticals (Basel)       Date:  2022-05-23

4.  Dosing Psychedelics and MDMA.

Authors:  Matthias E Liechti; Friederike Holze
Journal:  Curr Top Behav Neurosci       Date:  2022

5.  Effects of Acute Drug Administration on Emotion: A Review of Pharmacological MRI Studies.

Authors:  Kathryne Van Hedger; Leah M Mayo; Anya K Bershad; Racheal Madray; Harriet de Wit
Journal:  Curr Addict Rep       Date:  2021-03-14

6.  Self-blinding citizen science to explore psychedelic microdosing.

Authors:  Balázs Szigeti; Laura Kartner; Allan Blemings; Fernando Rosas; Amanda Feilding; David J Nutt; Robin L Carhart-Harris; David Erritzoe
Journal:  Elife       Date:  2021-03-02       Impact factor: 8.140

7.  MDLSD: study protocol for a randomised, double-masked, placebo-controlled trial of repeated microdoses of LSD in healthy volunteers.

Authors:  Robin J Murphy; Rachael L Sumner; William Evans; David Menkes; Ingo Lambrecht; Rhys Ponton; Frederick Sundram; Nicholas Hoeh; Sanya Ram; Lisa Reynolds; Suresh Muthukumaraswamy
Journal:  Trials       Date:  2021-04-23       Impact factor: 2.279

Review 8.  Psychedelic Therapy's Transdiagnostic Effects: A Research Domain Criteria (RDoC) Perspective.

Authors:  John R Kelly; Claire M Gillan; Jack Prenderville; Clare Kelly; Andrew Harkin; Gerard Clarke; Veronica O'Keane
Journal:  Front Psychiatry       Date:  2021-12-17       Impact factor: 4.157

9.  Pharmacokinetics and Pharmacodynamics of Lysergic Acid Diethylamide Microdoses in Healthy Participants.

Authors:  Friederike Holze; Matthias E Liechti; Nadia R P W Hutten; Natasha L Mason; Patrick C Dolder; Eef L Theunissen; Urs Duthaler; Amanda Feilding; Johannes G Ramaekers; Kim P C Kuypers
Journal:  Clin Pharmacol Ther       Date:  2020-10-18       Impact factor: 6.875

10.  Acute dose-dependent effects of lysergic acid diethylamide in a double-blind placebo-controlled study in healthy subjects.

Authors:  Friederike Holze; Patrick Vizeli; Laura Ley; Felix Müller; Patrick Dolder; Melanie Stocker; Urs Duthaler; Nimmy Varghese; Anne Eckert; Stefan Borgwardt; Matthias E Liechti
Journal:  Neuropsychopharmacology       Date:  2020-10-15       Impact factor: 7.853

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.